ATP (Apple Tree Partners) | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Company Directory for ATP (Apple Tree Partners)
ATP (Apple Tree Partners)
Overview
Established in 1999, this life sciences venture capital firm specializes in creating, incubating, and investing in biotechnology companies that develop innovative therapeutics for diseases such as cancer, neurological disorders, and infectious diseases. With over 25 years in the industry and $2.65 billion in committed capital, it maintains an exceptional track record in fund management and investment success.
The firm operates from offices in New York, London, San Francisco, and Cambridge, MA, supporting companies from early-stage concepts through IPOs with flexible capital, strategic insights, and operational resources. Its ATP R&D Labs in New Haven, Connecticut, launched in 2022, functions as an incubator and accelerator, providing services like compound screening and preclinical pharmacology. Notable investments include Deep Apple Therapeutics and Aileron Therapeutics, with a focus on advancing drug discovery and development in oncology, neurology, and infectious diseases.
Basic Information
| Industry | Venture Capital & Private Equity |
|---|---|
| Founded | 1999 |
| Revenue | 12.2M |
| Headquarters | 230 Park Avenue, Suite 2800, New York, NY 10169, United States |
| Languages | English |
Contact Details
- Phone: +1 617-401-2100
- Website: appletreepartners.com
- LinkedIn: linkedin.com/company/apple-tree-partners
Key Focus Areas & Initiatives
- Biotech and pharmaceutical investment
- Drug discovery and clinical development
- Venture partnership and strategic insight
- Operational resources for portfolio companies
- Oncology, neurology, infectious diseases
- Seed to IPO funding support
- R&D acceleration and incubator services
- Regulatory compliance guidance
- Research-driven enterprise growth
Technologies Used
- AI
- Amazon AWS
- DigitalOcean
- Google Analytics
- Google Maps
- Google Maps (Non Paid Users)
- Mimecast
- Mobile Friendly
- Nginx
- Outlook
- Remote
- Slack
- Typekit
- Ubuntu
- WordPress.org
Buyer Teams to Target
Investment & Portfolio Management
- Managing Partner
- Investment Director
- Venture Partner
- Associate, Portfolio Management
- Principal, Investments
- Due Diligence Analyst
Research & Scientific Affairs
- Head of R&D
- Scientific Director
- Preclinical Program Manager
- Clinical Development Lead
- Biotech Innovation Strategist
- Translational Science Manager
Operations & Compliance
- Chief Operating Officer
- Director of Regulatory Affairs
- Compliance Manager
- Corporate Counsel
- Accounting Manager
- Human Resources Director
IT & Digital Infrastructure
- Head of Information Technology
- Systems Administrator
- Cybersecurity Officer
- Cloud Services Manager
- Data Analytics Lead
- Software Solutions Architect
What They Buy
- Venture capital fund management software
- Research & laboratory equipment
- Clinical trial management systems
- Regulatory and compliance solutions
- Cloud infrastructure & hosting services
- Digital collaboration tools
- Financial analytics & reporting platforms
Signals to Watch
- π° New fundraising or committed capital announcements
- π Posting of jobs in investment, research, or compliance
- πΊοΈ Opening of new offices or expansion initiatives
- π§βπ¬ Launch of new biotech incubator or accelerator programs
- 𧬠Investments in emerging therapeutic areas or startups
- π¦ΈββοΈ Leadership changes among partners or scientific directors